A recent analysis indicated that switching from the standard-dose inactivated influenza vaccine to the recombinant influenza vaccine (RIV) could have prevented nearly 100,000 hospitalizations among ...

Credit: ImmunityBio. Developed by the Serum Institute of India, the rBCG product, which has been modified to improve its immunogenicity and safety, was evaluated in phase 1/2 clinical trials in Europe ...

Recombinant quadrivalent influenza vaccine (RIV4) and standard egg-based quadrivalent inactivated IV (IIV4) show comparable effectiveness in reducing influenza-related hospitalization among older ...

Sydney-based biotech company All G affirmed the GRAS status of its recombinant bovine lactoferrin, as the company tees up the availability of a human equivalent of the highly sought-after food and ...

Recombinant antibody technology has addressed many problems associated with hybridoma-based platforms, opening the door to a new class of biologics. Today, this technology continues to contribute to ...

Tuberculosis is a serious health threat, and the efficacy of the BCG vaccine against tuberculosis diminishes in adulthood, making booster vaccines a realistic option. Mycobacterial DNA-binding protein ...

The thought of your chromosomes breaking may send shivers down your spine. But for developing egg or sperm cells, it’s essential. In her laboratory, Lexy von Diezmann, a new College of Biological ...

Immune responses in a phase 2 clinical trial of peptide-based therapeutic human papillomavirus vaccine, PepCan, versus Candida adjuvant alone in treating cervical intraepithelial neoplasia 2/3. This ...

Recombinant protein vaccines, which are obtained by conventional genetic engineering, are based on the proteins of target pathogens that can activate our immune systems. Unlike other types of vaccines ...